Confluence Pharmaceuticals
2010
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Later Stage VC
LATEST DEAL TYPE
$805K
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of therapeutic medications intended for neurological development disorders. The company' focuses on therapeutic drug development, enabling patients to get medications to treat core social, communication and cognitive impairments associated with Fragile X Syndrome and Autism Spectrum Disorders.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Primary Office
- 4904 Deer Ridge Drive South
- Carmel, IN 46033
- United States
+1 (317) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Confluence Pharmaceuticals’s full profile, request a free trial.
Confluence Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 30-May-2019 | $805K | 00.000 | Completed | Generating Revenue | |
| 2. Later Stage VC | 03-Oct-2018 | 0000 | 00.000 | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A2) | 07-Nov-2017 | $1.3M | $1.3M | Completed | Generating Revenue |
Confluence Pharmaceuticals Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Janssen Research and Development | Corporate Backed or Acquired | Titusville, NJ | 000000&0 | |||
| 00000000 000000000 | Formerly VC-backed | Marlborough, MA | 0000 | 000000&0 | ||
| 00000000 | Corporation | Valby, Denmark | 0000 | |||
| 00000000 | Venture Capital-Backed | Baltimore, MD | 0 | 000.00 | 0000000000 | 000.00 |
| 000000 00000000000 | Corporation | Freemans Bay, New Zealand | 0 |
Confluence Pharmaceuticals Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Foundry Partners | PE-Backed Company | Minority | 000 0000 | 000000 0 | ||
| Indiana University Philanthropic Venture Fund | Other | Minority | 000 0000 | 000000 0 | ||
| Elevate Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Confluence Pharmaceuticals Executive Team (5)
Confluence Pharmaceuticals Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Boyd Sturdevant Jr. | Confluence Pharmaceuticals | Co-Founder and Chairman | 000 0000 | |
| Phil Lodato JD | Elevate Ventures | Board Member | 000 0000 | |
| Steven Johns | Confluence Pharmaceuticals | Co-Founder, Chief Executive Officer, President & Board Member | 000 0000 |